{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:25:38Z","timestamp":1791213938868,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,11,23]],"date-time":"2004-11-23T00:00:00Z","timestamp":1101168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2004,11,23]],"date-time":"2004-11-23T00:00:00Z","timestamp":1101168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>Human T-lymphotropic virus type-1 (HTLV-1) is a deltaretrovirus that causes adult T-cell leukemia\/lymphoma and is implicated in a variety of lymphocyte-mediated disorders. HTLV-1 contains both regulatory and accessory genes in four pX open reading frames. pX ORF-II encodes two proteins, p13<jats:sup>II<\/jats:sup> and p30<jats:sup>II<\/jats:sup>, which are incompletely defined in the virus life cycle or HTLV-1 pathogenesis. Proviral clones of the virus with pX ORF-II mutations diminish the ability of the virus to maintain viral loads <jats:italic>in vivo<\/jats:italic>. Exogenous expression of p30<jats:sup>II<\/jats:sup> differentially modulates CREB and Tax-responsive element-mediated transcription through its interaction with CREB-binding protein\/p300 and represses tax\/rex RNA nuclear export.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Herein, we further characterized the role of p30<jats:sup>II<\/jats:sup> in regulation of cellular gene expression, using stable p30<jats:sup>II<\/jats:sup> expression system employing lentiviral vectors to test cellular gene expression with Affymetrix U133A arrays, representing ~33,000 human genes. Reporter assays in Jurkat T cells and RT-PCR in Jurkat and primary CD4+ T-lymphocytes were used to confirm selected gene expression patterns. Our data reveals alterations of interrelated pathways of cell proliferation, T-cell signaling, apoptosis and cell cycle in p30<jats:sup>II<\/jats:sup> expressing Jurkat T cells. In all categories, p30<jats:sup>II<\/jats:sup> appeared to be an overall repressor of cellular gene expression, while selectively increasing the expression of certain key regulatory genes.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>We are the first to demonstrate that p30<jats:sup>II<\/jats:sup>, while repressing the expression of many genes, selectively activates key gene pathways involved in T-cell signaling\/activation. Collectively, our data suggests that this complex retrovirus, associated with lymphoproliferative diseases, relies upon accessory gene products to modify cellular environment to promote clonal expansion of the virus genome and thus maintain proviral loads <jats:italic>in vivo<\/jats:italic>.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1742-4690-1-39","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T00:25:30Z","timestamp":1105575930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes"],"prefix":"10.1186","volume":"1","author":[{"given":"Bindhu","family":"Michael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrithraj M","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Hiraragi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerold","family":"Feuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Boris-Lawrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Lairmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,11,23]]},"reference":[{"key":"39_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF02983553","volume":"78","author":"CR Bangham","year":"2003","unstructured":"Bangham CR: Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control. Int J Hematol. 2003, 78: 297-303.","journal-title":"Int J Hematol"},{"key":"39_CR2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1128\/MMBR.63.2.308-333.1999","volume":"63","author":"P Hollsberg","year":"1999","unstructured":"Hollsberg P: Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev. 1999, 63: 308-333.","journal-title":"Microbiol Mol Biol Rev"},{"key":"39_CR3","first-page":"3562","volume":"62","author":"CA Pise-Masison","year":"2002","unstructured":"Pise-Masison CA, Radonovich M, Mahieux R, Chatterjee P, Whiteford C, Duvall J, Guillerm C, Gessain A, Brady JN: Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res. 2002, 62: 3562-3571.","journal-title":"Cancer Res"},{"key":"39_CR4","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1182\/blood.V86.10.3619.bloodjournal86103619","volume":"86","author":"G Franchini","year":"1995","unstructured":"Franchini G: Molecular mechanisms of human T-cell leukemia\/lymphotropic virus type I infection. Blood. 1995, 86: 3619-3639.","journal-title":"Blood"},{"key":"39_CR5","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1038\/sj.onc.1202762","volume":"18","author":"P Heger","year":"1999","unstructured":"Heger P, Rosorius O, Hauber J, Stauber RH: Titration of cellular export factors, but not heteromultimerization, is the molecular mechanism of trans- dominant HTLV-1 Rex mutants. Oncogene. 1999, 18: 4080-4090. 10.1038\/sj.onc.1202762.","journal-title":"Oncogene"},{"key":"39_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-4690-1-20","volume":"1","author":"I Azran","year":"2004","unstructured":"Azran I, Schavinsky-Khrapunsky Y, Aboud M: Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology. 2004, 1: 20-10.1186\/1742-4690-1-20.","journal-title":"Retrovirology"},{"key":"39_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1128\/MMBR.66.3.396-406.2002","volume":"66","author":"B Albrecht","year":"2002","unstructured":"Albrecht B, Lairmore MD: Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol Mol Biol Rev. 2002, 66: 396-406. 10.1128\/MMBR.66.3.396-406.2002.","journal-title":"Microbiol Mol Biol Rev"},{"key":"39_CR8","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.2741\/1417","volume":"9","author":"B Michael","year":"2004","unstructured":"Michael B, Nair A, Lairmore MD: Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression. Front Biosci. 2004, 9: 2556-2576.","journal-title":"Front Biosci"},{"key":"39_CR9","doi-asserted-by":"publisher","first-page":"8813","DOI":"10.1073\/pnas.89.18.8813","volume":"89","author":"IJ Koralnik","year":"1992","unstructured":"Koralnik IJ, Gessain A, Klotman ME, Lo MA, Berneman ZN, Franchini G: Protein isoforms encoded by the pX region of human T-cell leukemia\/lymphotropic virus type I. Proc Natl Acad Sci U S A. 1992, 89: 8813-8817.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"39_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/sj.leu.2400665","volume":"11","author":"A Cereseto","year":"1997","unstructured":"Cereseto A, Berneman Z, Koralnik I, Vaughn J, Franchini G, Klotman ME: Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines. Leukemia. 1997, 11: 866-870. 10.1038\/sj.leu.2400665.","journal-title":"Leukemia"},{"key":"39_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<196::AID-IJC12>3.0.CO;2-G","volume":"71","author":"YMA Chen","year":"1997","unstructured":"Chen YMA, Chen SH, Fu CY, Chen JY, Osame M: Antibody reactivities to tumor-suppressor protein p53 and HTLV-I Tof Rex and Tax in HTLV-I-infected people with differing clinical status. Int J Cancer. 1997, 71: 196-202.","journal-title":"Int J Cancer"},{"key":"39_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1006\/viro.2000.0406","volume":"274","author":"GA Dekaban","year":"2000","unstructured":"Dekaban GA, Peters AA, Mulloy JC, Johnson JM, Trovato R, Rivadeneira E, Franchini G: The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits. Virology. 2000, 274: 86-93. 10.1006\/viro.2000.0406.","journal-title":"Virology"},{"key":"39_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.191.3.567","volume":"191","author":"C Pique","year":"2000","unstructured":"Pique C, Uretavidal A, Gessain A, Chancerel B, Gout O, Tamouza R, Agis F, Dokhelar MC: Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J Exp Med. 2000, 191: 567-572. 10.1084\/jem.191.3.567.","journal-title":"J Exp Med"},{"key":"39_CR14","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1128\/JVI.78.8.3837-3845.2004","volume":"78","author":"LR Silverman","year":"2004","unstructured":"Silverman LR, Phipps AJ, Montgomery A, Ratner L, Lairmore MD: Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol. 2004, 78: 3837-3845. 10.1128\/JVI.78.8.3837-3845.2004.","journal-title":"J Virol"},{"key":"39_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1128\/JVI.74.3.1094-1100.2000","volume":"74","author":"JT Bartoe","year":"2000","unstructured":"Bartoe JT, Albrecht B, Collins ND, Robek MD, Ratner L, Green PL, Lairmore MD: Functional role of pX open reading frame II of human T- lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol. 2000, 74: 1094-1100. 10.1128\/JVI.74.3.1094-1100.2000.","journal-title":"J Virol"},{"key":"39_CR16","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood.V91.12.4701.412k23_4701_4707","volume":"91","author":"ND Collins","year":"1998","unstructured":"Collins ND, Newbound GC, Albrecht B, Beard JL, Ratner L, Lairmore MD: Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood. 1998, 91: 4701-4707.","journal-title":"Blood"},{"key":"39_CR17","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1128\/jvi.67.4.2360-2366.1993","volume":"67","author":"IJ Koralnik","year":"1993","unstructured":"Koralnik IJ, Fullen J, Franchini G: The p12I, p13II, and p30II proteins encoded by human T-cell leukemia\/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol. 1993, 67: 2360-2366.","journal-title":"J Virol"},{"key":"39_CR18","doi-asserted-by":"publisher","first-page":"11270","DOI":"10.1128\/JVI.74.23.11270-11277.2000","volume":"74","author":"W Zhang","year":"2000","unstructured":"Zhang W, Nisbet JW, Bartoe JT, Ding W, Lairmore MD: Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters. J Virol. 2000, 74: 11270-11277. 10.1128\/JVI.74.23.11270-11277.2000.","journal-title":"J Virol"},{"key":"39_CR19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/jvi.71.1.75-83.1997","volume":"71","author":"DM D'Agostino","year":"1997","unstructured":"D'Agostino DM, Ciminale V, Zotti L, Rosato A, Chieco-Bianchi L: The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex. J Virol. 1997, 71: 75-83.","journal-title":"J Virol"},{"key":"39_CR20","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1128\/jvi.66.3.1737-1745.1992","volume":"66","author":"V Ciminale","year":"1992","unstructured":"Ciminale V, Pavlakis GN, Derse D, Cunningham CP, Felber BK: Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: Novel mRNAs and proteins produced by HTLV type I. J Virol. 1992, 66: 1737-1745.","journal-title":"J Virol"},{"key":"39_CR21","doi-asserted-by":"publisher","first-page":"9885","DOI":"10.1128\/JVI.75.20.9885-9895.2001","volume":"75","author":"W Zhang","year":"2001","unstructured":"Zhang W, Nisbet JW, Albrecht B, Ding W, Kashanchi F, Bartoe JT, Lairmore MD: Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein\/p300. J Virol. 2001, 75: 9885-9895. 10.1128\/JVI.75.20.9885-9895.2001.","journal-title":"J Virol"},{"key":"39_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nm984","volume":"10","author":"C Nicot","year":"2004","unstructured":"Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G: HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med. 2004, 10: 197-201. 10.1038\/nm984.","journal-title":"Nat Med"},{"key":"39_CR23","doi-asserted-by":"publisher","first-page":"11077","DOI":"10.1128\/JVI.78.20.11077-11083.2004","volume":"78","author":"I Younis","year":"2004","unstructured":"Younis I, Khair L, Dundr M, Lairmore MD, Franchini G, Green PL: Repression of Human T-Cell Leukemia Virus Type 1 and Type 2 Replication by a Viral mRNA-Encoded Posttranscriptional Regulator. J Virol. 2004, 78: 11077-11083. 10.1128\/JVI.78.20.11077-11083.2004.","journal-title":"J Virol"},{"key":"39_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/sj.onc.1202405","volume":"18","author":"EW Harhaj","year":"1999","unstructured":"Harhaj EW, Good LF, Xiao GT, Sun SC: Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation. Oncogene. 1999, 18: 1341-1349. 10.1038\/sj.onc.1202405.","journal-title":"Oncogene"},{"key":"39_CR25","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1089\/08892220050193164","volume":"16","author":"FC de La","year":"2000","unstructured":"de La FC, Deng L, Santiago F, Arce L, Wang L, Kashanchi F: Gene expression array of HTLV type 1-infected T cells: Up-regulation of transcription factors and cell cycle genes. AIDS Res Hum Retroviruses. 2000, 16: 1695-1700. 10.1089\/08892220050193164.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"39_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/j.1349-7006.2000.tb00892.x","volume":"91","author":"T Kohno","year":"2000","unstructured":"Kohno T, Moriuchi R, Katamine S, Yamada Y, Tomonaga M, Matsuyama T: Identification of genes associated with the progression of adult T cell leukemia (ATL). Jpn J Cancer Res. 2000, 91: 1103-1110.","journal-title":"Jpn J Cancer Res"},{"key":"39_CR27","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1038\/sj.onc.1204513","volume":"20","author":"PW Ng","year":"2001","unstructured":"Ng PW, Iha H, Iwanaga Y, Bittner M, Chen Y, Jiang Y, Gooden G, Trent JM, Meltzer P, Jeang KT, Zeichner SL: Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK- 3 mixed lineage kinase involvement in Tax-mediated NF-kappaB activation. Oncogene. 2001, 20: 4484-4496. 10.1038\/sj.onc.1204513.","journal-title":"Oncogene"},{"key":"39_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1073\/pnas.98.1.31","volume":"98","author":"C Li","year":"2001","unstructured":"Li C, Wong WH: Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A. 2001, 98: 31-36. 10.1073\/pnas.011404098.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"39_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000, 25: 25-29. 10.1038\/75556.","journal-title":"Nat Genet"},{"key":"39_CR30","first-page":"31","volume":"50","author":"E Konikova","year":"2003","unstructured":"Konikova E, Kusenda J: Altered expression of p53 and MDM2 proteins in hematological malignancies. Neoplasma. 2003, 50: 31-40.","journal-title":"Neoplasma"},{"key":"39_CR31","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1073\/pnas.0334477100","volume":"100","author":"MA McCoy","year":"2003","unstructured":"McCoy MA, Gesell JJ, Senior MM, Wyss DF: Flexible lid to the p53-binding domain of human Mdm2: implications for p53 regulation. Proc Natl Acad Sci U S A. 2003, 100: 1645-1648. 10.1073\/pnas.0334477100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"39_CR32","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1242\/dev.126.21.4807","volume":"126","author":"P Vaudin","year":"1999","unstructured":"Vaudin P, Delanoue R, Davidson I, Silber J, Zider A: TONDU (TDU), a novel human protein related to the product of vestigial (vg) gene of Drosophila melanogaster interacts with vertebrate TEF factors and substitutes for Vg function in wing formation. Development. 1999, 126: 4807-4816.","journal-title":"Development"},{"key":"39_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1006\/geno.1995.1040","volume":"27","author":"N Tommerup","year":"1995","unstructured":"Tommerup N, Vissing H: Isolation and fine mapping of 16 novel human zinc finger-encoding cDNAs identify putative candidate genes for developmental and malignant disorders. Genomics. 1995, 27: 259-264. 10.1006\/geno.1995.1040.","journal-title":"Genomics"},{"key":"39_CR34","doi-asserted-by":"publisher","first-page":"27629","DOI":"10.1074\/jbc.272.44.27629","volume":"272","author":"A Takeshita","year":"1997","unstructured":"Takeshita A, Cardona GR, Koibuchi N, Suen CS, Chin WW: TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J Biol Chem. 1997, 272: 27629-27634. 10.1074\/jbc.272.44.27629.","journal-title":"J Biol Chem"},{"key":"39_CR35","doi-asserted-by":"publisher","first-page":"11423","DOI":"10.1073\/pnas.95.19.11423","volume":"95","author":"YT Ju","year":"1998","unstructured":"Ju YT, Chang AC, She BR, Tsaur ML, Hwang HM, Chao CC, Cohen SN, Lin-Chao S: gas7: A gene expressed preferentially in growth-arrested fibroblasts and terminally differentiated Purkinje neurons affects neurite formation. Proc Natl Acad Sci U S A. 1998, 95: 11423-11428. 10.1073\/pnas.95.19.11423.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"39_CR36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng904","volume":"31","author":"N Anand","year":"2002","unstructured":"Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH, Collins C, Gray JW, Diebold J, Demetrick DJ, Lee JM: Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet. 2002, 31: 301-305.","journal-title":"Nat Genet"},{"key":"39_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1014256417651","volume":"22","author":"H Bour-Jordan","year":"2002","unstructured":"Bour-Jordan H, Blueston JA: CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol. 2002, 22: 1-7. 10.1023\/A:1014256417651.","journal-title":"J Clin Immunol"},{"key":"39_CR38","doi-asserted-by":"publisher","first-page":"14590","DOI":"10.1074\/jbc.275.19.14590","volume":"275","author":"JG Nemorin","year":"2000","unstructured":"Nemorin JG, Duplay P: Evidence that Llck-mediated phosphorylation of p56dok and p62dok may play a role in CD2 signaling. J Biol Chem. 2000, 275: 14590-14597. 10.1074\/jbc.275.19.14590.","journal-title":"J Biol Chem"},{"key":"39_CR39","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0006-291X(03)00268-7","volume":"302","author":"C Hurd","year":"2003","unstructured":"Hurd C, Rozengurt E: Uncoupling of protein kinase D from suppression of EGF-dependent c-Jun phosphorylation in cancer cells. Biochem Biophys Res Commun. 2003, 302: 800-804. 10.1016\/S0006-291X(03)00268-7.","journal-title":"Biochem Biophys Res Commun"},{"key":"39_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0962-8924(02)02262-6","volume":"12","author":"J Van Lint","year":"2002","unstructured":"Van Lint J, Rykx A, Maeda Y, Vantus T, Sturany S, Malhotra V, Vandenheede JR, Seufferlein T: Protein kinase D: an intracellular traffic regulator on the move. Trends Cell Biol. 2002, 12: 193-200. 10.1016\/S0962-8924(02)02262-6.","journal-title":"Trends Cell Biol"},{"key":"39_CR41","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1089\/08892220050193001","volume":"16","author":"SC Sun","year":"2000","unstructured":"Sun SC, Harhaj EW, Xiao G, Good L: Activation of I-kappaB kinase by the HTLV type 1 tax protein: mechanistic insights into the adaptor function of IKKgamma. AIDS Res Hum Retroviruses. 2000, 16: 1591-1596. 10.1089\/08892220050193001.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"39_CR42","doi-asserted-by":"publisher","first-page":"14675","DOI":"10.1074\/jbc.M008343200","volume":"276","author":"R Arnold","year":"2001","unstructured":"Arnold R, Liou J, Drexler HC, Weiss A, Kiefer F: Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor of NFkappaB. J Biol Chem. 2001, 276: 14675-14684. 10.1074\/jbc.M008343200.","journal-title":"J Biol Chem"},{"key":"39_CR43","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1152\/advan.00043.2002","volume":"26","author":"D Murphy","year":"2002","unstructured":"Murphy D: Gene expression studies using microarrays: principles, problems, and prospects. Adv Physiol Educ. 2002, 26: 256-270.","journal-title":"Adv Physiol Educ"},{"key":"39_CR44","doi-asserted-by":"publisher","first-page":"6751","DOI":"10.1038\/sj.onc.1205843","volume":"21","author":"Y Mamane","year":"2002","unstructured":"Mamane Y, Grandvaux N, Hernandez E, Sharma S, Innocente SA, Lee JM, Azimi N, Lin R, Hiscott J: Repression of IRF-4 target genes in human T cell leukemia virus-1 infection. Oncogene. 2002, 21: 6751-6765. 10.1038\/sj.onc.1205843.","journal-title":"Oncogene"},{"key":"39_CR45","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.virol.2003.09.010","volume":"317","author":"GL Princler","year":"2003","unstructured":"Princler GL, Julias JG, Hughes SH, Derse D: Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs. Virology. 2003, 317: 136-145. 10.1016\/j.virol.2003.09.010.","journal-title":"Virology"},{"key":"39_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1074-7613(00)80464-1","volume":"8","author":"H Yoshida","year":"1998","unstructured":"Yoshida H, Nishina H, Takimoto H, Marengere LE, Wakeham AC, Bouchard D, Kong YY, Ohteki T, Shahinian A, Bachmann M, Ohashi PS, Penninger JM, Crabtree GR, Mak TW: The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity. 1998, 8: 115-124. 10.1016\/S1074-7613(00)80464-1.","journal-title":"Immunity"},{"key":"39_CR47","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1089\/08892220050193029","volume":"16","author":"M Fujii","year":"2000","unstructured":"Fujii M, Iwai K, Oie M, Fukushi M, Yamamoto N, Kannagi M, Mori N: Activation of oncogenic transcription factor AP-1 in T cells infected with human T cell leukemia virus type 1. AIDS Res Hum Retroviruses. 2000, 16: 1603-1606. 10.1089\/08892220050193029.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"39_CR48","first-page":"4939","volume":"60","author":"N Mori","year":"2000","unstructured":"Mori N, Ueda A, Ikeda S, Yamasaki Y, Yamada Y, Tomonaga M, Morikawa S, Geleziunas R, Yoshimura T, Yamamoto N: Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites. Cancer Res. 2000, 60: 4939-4945.","journal-title":"Cancer Res"},{"key":"39_CR49","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1128\/JVI.76.7.3493-3501.2002","volume":"76","author":"B Albrecht","year":"2002","unstructured":"Albrecht B, D'Souza CD, Ding W, Tridandapani S, Coggeshall KM, Lairmore MD: Activation of nuclear factor of activated T cells by human T- lymphotropic virus type 1 accessory protein p12(I). J Virol. 2002, 76: 3493-3501. 10.1128\/JVI.76.7.3493-3501.2002.","journal-title":"J Virol"},{"key":"39_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1006\/viro.2000.0669","volume":"279","author":"K Iwai","year":"2001","unstructured":"Iwai K, Mori N, Oie M, Yamamoto N, Fujii M: Human T-Cell Leukemia Virus Type 1 Tax Protein Activates Transcription through AP-1 Site by Inducing DNA Binding Activity in T Cells. Virology. 2001, 279: 38-46. 10.1006\/viro.2000.0669.","journal-title":"Virology"},{"key":"39_CR51","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/384641a0","volume":"384","author":"AJ Bannister","year":"1996","unstructured":"Bannister AJ, Kouzarides T: The CBP co-activator is a histone acetyltransferase. Nature. 1996, 384: 641-643. 10.1038\/384641a0.","journal-title":"Nature"},{"key":"39_CR52","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1084\/jem.187.12.2031","volume":"187","author":"C Garcia-Rodriguez","year":"1998","unstructured":"Garcia-Rodriguez C, Rao A: Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300\/CREB-binding protein (CBP). J Exp Med. 1998, 187: 2031-2036. 10.1084\/jem.187.12.2031.","journal-title":"J Exp Med"},{"key":"39_CR53","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0042-6822(03)00164-8","volume":"310","author":"AL Lahti","year":"2003","unstructured":"Lahti AL, Manninen A, Saksela K: Regulation of T cell activation by HIV-1 accessory proteins: Vpr acts via distinct mechanisms to cooperate with Nef in NFAT-directed gene expression and to promote transactivation by CREB. Virology. 2003, 310: 190-196. 10.1016\/S0042-6822(03)00164-8.","journal-title":"Virology"},{"key":"39_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-4690-1-6","volume":"1","author":"K Kehn","year":"2004","unstructured":"Kehn K, Deng L, de La FC, Strouss K, Wu K, Maddukuri A, Baylor S, Rufner R, Pumfery A, Bottazzi ME, Kashanchi F: The role of cyclin D2 and p21\/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology. 2004, 1: 6-10.1186\/1742-4690-1-6.","journal-title":"Retrovirology"},{"key":"39_CR55","first-page":"989","volume":"12","author":"M Ohta","year":"1996","unstructured":"Ohta M, Nagai H, Nyunoya H, Shimotohno K: Src-homology domain 2 is responsible for transcriptional suppression induced by expression of Lck. Oncogene. 1996, 12: 989-997.","journal-title":"Oncogene"},{"key":"39_CR56","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/0888-7543(92)90138-I","volume":"13","author":"C Li","year":"1992","unstructured":"Li C, Lusis AJ, Sparkes R, Tran SM, Gaynor R: Characterization and chromosomal mapping of the gene encoding the cellular DNA binding protein HTLF. Genomics. 1992, 13: 658-664. 10.1016\/0888-7543(92)90138-I.","journal-title":"Genomics"},{"key":"39_CR57","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1089\/08892220050193290","volume":"16","author":"S Wrzesinski","year":"2000","unstructured":"Wrzesinski S, Seguin R, Liu Y, Domville S, Planelles V, Massa P, Barker E, Antel J, Feuer G: HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors. AIDS Res Hum Retroviruses. 2000, 16: 1771-1776. 10.1089\/08892220050193290.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"39_CR58","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1006\/viro.1994.1581","volume":"204","author":"JT Kimata","year":"1994","unstructured":"Kimata JT, Wong F, Wang J, Ratner L: Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology. 1994, 204: 656-664. 10.1006\/viro.1994.1581.","journal-title":"Virology"},{"key":"39_CR59","doi-asserted-by":"publisher","first-page":"11027","DOI":"10.1128\/JVI.77.20.11027-11039.2003","volume":"77","author":"W Ding","year":"2003","unstructured":"Ding W, Kim SJ, Nair AM, Michael B, Boris-Lawrie K, Tripp A, Feuer G, Lairmore MD: Human T-Cell Lymphotropic Virus Type 1 p12(I) Enhances Interleukin-2 Production during T-Cell Activation. J Virol. 2003, 77: 11027-11039. 10.1128\/JVI.77.20.11027-11039.2003.","journal-title":"J Virol"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-1-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1742-4690-1-39\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-1-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:31:06Z","timestamp":1728304266000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-1-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,23]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-1-39","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,23]]},"assertion":[{"value":"19 August 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"39"}}